SCHEMBL16806414

SCHEMBL16806414

CC(Br)c1oc(=O)c2ccccc2c1-c1ccc(CN2CCOCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ HRH3 Q9Y5N1 2/20 0.47
▸ TNKS O95271 1/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PDK1 Q15118 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ TLR8 Q9NR97 1/20 0.41
▸ TLR7 Q9NYK1 1/20 0.41
▸ CHEK1 O14757 1/20 0.41
▸ CDK4 P11802 1/20 0.40
▸ CCND1 P24385 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL16783813 0.99 NPC1 (0.51) NPC1RAB9AATMHRH3TNKS
SCHEMBL16806398 0.89 NPC1 (0.49) NPC1RAB9AATMHRH3TNKS
SCHEMBL16806411 0.83 NPC1 (0.53) NPC1RAB9AHRH3CHEK1MEN1
Bromide SCHEMBL16783514 0.82 NPC1 (0.52) NPC1RAB9AHRH3CHEK1MEN1
SCHEMBL16806424 0.82 ALDH1A1 (0.56) NPC1ALDH1A1CYP1A2CYP2D6CYP2C9
SCHEMBL16806412 0.81 KDM5B (0.43) NPC1RAB9AATMHRH3ALDH1A1
SCHEMBL16783429 0.81 ALDH1A1 (0.44) HRH3ALDH1A1CYP1A2CYP2C19TSHR
Bromide SCHEMBL16783884 0.81 ALDH1A1 (0.55) NPC1ALDH1A1CYP1A2CYP2D6CYP2C9
Bromide SCHEMBL16783654 0.80 KDM5B (0.43) NPC1RAB9AATMHRH3ALDH1A1
SCHEMBL16783834 0.80 ACHE (0.47) HRH3ALDH1A1CYP2D6CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9321776-B2 Isochromene derivatives as phoshoinositide 3-kinases inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-04-26 — — US disclosed
US-9321776-B2 Isochromene derivatives as phoshoinositide 3-kinases inhibitors CHIESI FARMACEUTICI S.P.A. (IT) 2016-04-26 — — US disclosed
US-20150166549-A1 ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-18 — — US disclosed
US-20150166549-A1 ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2015-06-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166549-A1 ISOCHROMENE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS PIKFYVE, IP6K2, IP6K3 NPC1 1111/4885RAB9A 679/4885ATM 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback